I Prescribe GLP-1s: What The Ozempic Conversation Is Missing
An interesting article and discussion on the use of GLP-1s in weight loss, covering the benefits, complications, proper use, and side effects. The article also explores some of the newer drugs emerging, including glucagon agonists and hormones for appetite suppression.
I Prescribe GLP-1s: What To Ozempic Conversation Is Missing - MindBodyGreen
American College of Gastroenterology Latest to Criticize UHC
The latest in a long line of associations and professional groups expressing skepticism about insurers practicing 'up-to-date and evidence-based medicine.' In this case, it's about the UnitedHealthcare gold card. We side with these groups on the issue: Who is paying for prior authorization (PA) decisions, and what is their primary interest? However, some optimistic doctors support the streamlined process.
American College of Gastroenterology latest to criticize UHC - Beckers
Appellate Court Vacates No Surprises Act Rule That Favors Insurers
Specifically, this issue is based on the Supreme Court’s decision regarding 'Chevron deference.' While more cases are likely to follow, the practice of insurers handling out-of-network providers or picking and choosing which patient treatments they pay for should never have been left to the insurers. Arbitration was supposed to be the solution, but the ruling found that ordering arbitration exceeds the authority of the act. (It also raises significant concerns about regulatory capture.)
One has to question how we reached the point where insurers are deciding who they pay, rather than simply determining whether appropriate care was provided for their customer—the patient. But then again, is the patient really the customer anymore?
Chances are, this issue will end up back in Congress, unless lawmakers find a way to avoid making a decision.
Appellate Court Vacates No Surprises Act Rule that Favors Insurers - AMA
|